Ceftazidime/avibactam group:None

2 trials

Sponsors

Shandong Provincial Hospital Affiliated to Shandong First Medical University

Conditions

Multi-drug-resistant Gram-negative bacteria pneumonia patientsinfections due to extensively drug-resistant Gram-negative bacteria

Unknown Phase

Ceftazidime/avibactam versus polymyxin B in the treatment of infections due to extensively drug-resistant Gram-negative bacteria

Active, not recruitingChiCTR2300078790

Shandong Provincial Hospital Affiliated to Shandong First Medical Universityinfections due to extensively drug-resistant Gram-negative bacteria

Start: 2023-12-21Updated: 2024-01-08

Intravenous plus nebulized polymyxins versus ceftazidime/avibactam for multi-drug-resistant Gram-negative bacteria pneumonia: a target trial emulation

Active, not recruitingChiCTR2500111039

Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityMulti-drug-resistant Gram-negative bacteria pneumonia patients

Start: 2025-10-24Updated: 2025-10-27

Related Papers

Comparing ceftazidime/avibactam and polymyxin B for treating carbapenem-resistant organisms infections: A propensity score-matched retrospective cohort study.

2024-12-20